187 related articles for article (PubMed ID: 16449971)
1. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Ren Y; Chan HM; Fan J; Xie Y; Chen YX; Li W; Jiang GP; Liu Q; Meinhardt A; Tam PK
Oncogene; 2006 Jun; 25(25):3501-8. PubMed ID: 16449971
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
Ren Y; Chan HM; Li Z; Lin C; Nicholls J; Chen CF; Lee PY; Lui V; Bacher M; Tam PK
Oncogene; 2004 May; 23(23):4146-54. PubMed ID: 15064733
[TBL] [Abstract][Full Text] [Related]
3. Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells.
Fan J; Chen Y; Chan HM; Tam PK; Ren Y
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17751-6. PubMed ID: 16314559
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
[TBL] [Abstract][Full Text] [Related]
5. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Sun B; Nishihira J; Suzuki M; Fukushima N; Ishibashi T; Kondo M; Sato Y; Todo S
Int J Mol Med; 2003 Oct; 12(4):633-41. PubMed ID: 12964047
[TBL] [Abstract][Full Text] [Related]
6. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
Hecht M; Schulte JH; Eggert A; Wilting J; Schweigerer L
Carcinogenesis; 2005 Dec; 26(12):2105-15. PubMed ID: 16051641
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
8. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Tang XX; Zhao H; Robinson ME; Cohen B; Cnaan A; London W; Cohn SL; Cheung NK; Brodeur GM; Evans AE; Ikegaki N
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10936-41. PubMed ID: 10984508
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Bacher M; Schrader J; Thompson N; Kuschela K; Gemsa D; Waeber G; Schlegel J
Am J Pathol; 2003 Jan; 162(1):11-7. PubMed ID: 12507885
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
Sun B; Nishihira J; Yoshiki T; Kondo M; Sato Y; Sasaki F; Todo S
Clin Cancer Res; 2005 Feb; 11(3):1050-8. PubMed ID: 15709171
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma.
Marcus K; Johnson M; Adam RM; O'Reilly MS; Donovan M; Atala A; Freeman MR; Soker S
Neuropathology; 2005 Sep; 25(3):178-87. PubMed ID: 16193833
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.
Yao K; Shida S; Selvakumaran M; Zimmerman R; Simon E; Schick J; Haas NB; Balke M; Ross H; Johnson SW; O'Dwyer PJ
Clin Cancer Res; 2005 Oct; 11(20):7264-72. PubMed ID: 16243796
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Ren Y; Tsui HT; Poon RT; Ng IO; Li Z; Chen Y; Jiang G; Lau C; Yu WC; Bacher M; Fan ST
Int J Cancer; 2003 Oct; 107(1):22-9. PubMed ID: 12925952
[TBL] [Abstract][Full Text] [Related]
15. Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.
Zhou Q; Yan X; Gershan J; Orentas RJ; Johnson BD
J Immunol; 2008 Aug; 181(3):1877-86. PubMed ID: 18641325
[TBL] [Abstract][Full Text] [Related]
16. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
18. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas.
Hecht M; Papoutsi M; Tran HD; Wilting J; Schweigerer L
Cancer Res; 2004 Sep; 64(17):6109-18. PubMed ID: 15342394
[TBL] [Abstract][Full Text] [Related]
20. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]